Circle Pharma
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
169 Harbor Way, South San Francisco, Cal...Phone Number
(650) 825-4099Website
www.circlepharma.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
2
1
About Circle Pharma
Circle Pharma is a clinical-stage biopharmaceutical company developing targeted macrocycle therapies for cancer and other serious illnesses. Its proprietary platform enables the discovery of cell-permeable and orally bioavailable medicines, with a pipeline focused on cyclin-targeted treatments for cancers including breast cancer.Explore more
Circle Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Circle Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Circle Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Circle Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Circle Pharma is spiking on competitors!
Click to see if Circle Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Circle Pharma
Product Launch: Get notified when Circle Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Circle Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Circle Pharma has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Circle Pharma
Find 2 more new buyers
Compare Similar Companies to Circle Pharma
Compare insights from companies similar to Circle Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Circle Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Circle Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Circle Pharma.
Circle Pharma financials insights
Gather financial insights about Circle Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$3.8M
2020
Series B
$45M
2021
Series C
$66M
2024
Series D
$90M
2026
Series E
$92.5M
Circle Pharma Tech Stack
A closer look at the technologies used by Circle Pharma
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Events, Finance, Investor Relations
Person-Based
Person-Based
Circle Pharma News & Media
Circle Pharma appoints Anne Borgman as Chief Medical Officer - PMLiVE
Borgman brings specialist expertise in oncology drug development to the roleCircle Pharma Appoints Rob Lauzen as Chief Financial Officer - Bluefield Daily Telegraph
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 3, 2025--Circle Pharma Appoints Rob Lauzen as Chief Financial Officer - Yahoo Finance
SOUTH SAN FRANCISCO, Calif., November 03, 2025--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced the appointment of Rob Lauzen as chief financial officer. Mr. Lauzen brings deep financial expertise and broad experience within the life sciences industry, having most recently served as chief financial officer of Prilenia Therapeutics, where he oversaw all aspects of the company’s capital strategyCircle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Biotech--Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to CID-078 for the treatment of small cell lung cancer (SCLC). Small-cell lung cancer is a highly aggressive form of lung cancer that accounts for approximately 13–15% of all lung cancer cases1 and is strongly li
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Circle Pharma
Sign Up For FreeTo access detailed company insights
Circle Pharma is a clinical-stage biopharmaceutical company developing targeted macrocycle therapies for cancer and other serious illnesses. Its proprietary platform enables the discovery of cell-permeable and orally bioavailable medicines, with a pipeline focused on cyclin-targeted treatments for cancers including breast cancer.... Read More
